Masis Isikbay, MD



Hashim D, Gonzalez-Feliciano AG, Ahearn TU, Pettersson A, Barber L, Pernar CH, Ebot EM, Isikbay M, Finn SP, Giovannucci EL, Lis RT, Loda M, Parmigiani G, Lotan T, Kantoff PW, Mucci LA, Graff RE. Family history of prostate cancer and the incidence of ERG- and phosphatase and tensin homolog-defined prostate cancer. Int J Cancer. 2020 May 15; 146(10):2694-2702.
House L, Seminerio MJ, Mirkov S, Ramirez J, Skor M, Sachleben JR, Isikbay M, Singhal H, Greene GL, Vander Griend D, Conzen SD, Ratain MJ. Metabolism of megestrol acetate in vitro and the role of oxidative metabolites. Xenobiotica. 2018 Oct; 48(10):973-983.
Zareba P, Flavin R, Isikbay M, Rider JR, Gerke TA, Finn S, Pettersson A, Giunchi F, Unger RH, Tinianow AM, Andersson SO, Andrén O, Fall K, Fiorentino M, Mucci LA. Perineural Invasion and Risk of Lethal Prostate Cancer. Cancer Epidemiol Biomarkers Prev. 2017 05; 26(5):719-726.
Kregel S, Chen JL, Tom W, Krishnan V, Kach J, Brechka H, Fessenden TB, Isikbay M, Paner GP, Szmulewitz RZ, Vander Griend DJ. Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer. Oncotarget. 2016 May 03; 7(18):26259-74.
Kibel AS, Ahn J, Isikbay M, Klim A, Wu WS, Hayes RB, Isaacs WB, Daw EW. Genetic variants in cell cycle control pathway confer susceptibility to aggressive prostate carcinoma. Prostate. 2016 Apr; 76(5):479-90.
Reyes EE, Gillard M, Duggan R, Wroblewski K, Kregel S, Isikbay M, Kach J, Brechka H, Weele DJ, Szmulewitz RZ, Griend DJ. Molecular analysis of CD133-positive circulating tumor cells from patients with metastatic castration-resistant prostate cancer. J Transl Sci. 2015 Jul; 1(1).
Tara L. Maginnis, Masis Isikbay, Spencer G. Degerstedt, Timothy J. Luethke, Matthew Ortman. The effects of cheliped autotomy and regeneration on aggression in purple shore crabs (Hemigrapsus nudus). Marine and Freshwater Behaviour and Physiology. 2015 Jul 4; 48(4):241-251.
Reyes EE, VanderWeele DJ, Isikbay M, Duggan R, Campanile A, Stadler WM, Vander Griend DJ, Szmulewitz RZ. Quantitative characterization of androgen receptor protein expression and cellular localization in circulating tumor cells from patients with metastatic castration-resistant prostate cancer. J Transl Med. 2014 Nov 26; 12:313.
Isikbay M, Otto K, Kregel S, Kach J, Cai Y, Vander Griend DJ, Conzen SD, Szmulewitz RZ. Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer. Horm Cancer. 2014 Apr; 5(2):72-89.
Russell Zelig Szmulewitz, Steve Kregel, Masis Isikbay, Yi Cai, James Lin Chen, Donald J Vander Griend. Androgen receptor independent acquired mechanisms of resistance to enzalutamide in castration-resistant prostate cancer. Journal of Clinical Oncology. 2014 Feb 1; 32(4_suppl):129-129.
David James VanderWeele, Masis Isikbay, Edwin Reyes, Ryan Duggan, Alicia J. Wyche, Walter Michael Stadler, Donald Vander Griend, Russell Zelig Szmulewitz. Feasibility of multimodal molecular characterization of the androgen receptor (AR) in circulating tumor cells (CTCs) from patients with castrate-resistant prostate cancer (CRPC). Journal of Clinical Oncology. 2014 Feb 1; 32(4_suppl):133-133.
Amelia Ahern-Rindell, Masis Isikbay. A size comparison of beta-galactosidase isolated from fibroblasts from normal and GM1-affected sheep. Molecular Genetics and Metabolism. 2013 Feb 1; 108(2):s17.
Amelia Ahern-Rindell, Masis Isikbay, Bethany McInturff, Megan Supinski. Evaluation of GLB1 In a Novel Ovine Model of GM1-Gangliosidosis. Molecular Genetics and Metabolism. 2012 Feb 1; 105(2):s15.